Thomas M. Pearce

Abstract

David E. Breen, Alexis B. Carter, Pinky A. Bautista, 2000, European Neuropsychopharmacology.

Homozygous deletion of CDKN2A by fluorescence in situ hybridization is prognostic in grade 4, but not grade 2 or 3, IDH-mutant astrocytomas

Daniel F Marker, Thomas M. Pearce, T. Pearce, 2020, Acta neuropathologica communications.

The dominant TP53 hotspot mutation in IDH-mutant astrocytoma, R273C, has distinctive pathologic features and sex-specific prognostic implications

S. Agnihotri, G. Murdoch, Daniel F Marker, 2021, Neuro-oncology advances.

The spectrum of rare central nervous system (CNS) tumors with EWSR1‐non‐ETS fusions: experience from three pediatric institutions with review of the literature

Marilyn M. Li, S. Rossi, E. Miele, 2020, Brain pathology.

Immunoglobulin G4 hypophysitis in a 63-year-old woman with no autoimmune history: a case report

Thomas M Pearce, E. Wang, P. Gardner, 2021, Journal of Medical Case Reports.

Intracranial Myxoid Mesenchymal Tumor with Rare EWSR1-CREM Translocation

Thomas M Pearce, M. Mcdowell, Michael D. White, 2019, Pediatric Neurosurgery.

The risk to future pregnancies of transfusing Rh(D)‐negative females of childbearing potential with Rh(D)‐positive red blood cells during trauma resuscitation is dependent on their age at transfusion

Thomas M Pearce, J. Sperry, D. Triulzi, 2021, Vox sanguinis.

Interactive Browser-Based Genomics Data Visualization Tools for Translational and Clinical Laboratory Applications.

Somak Roy, Thomas M Pearce, Marina M Nikiforova, 2019, The Journal of molecular diagnostics : JMD.

Immuno-PET Imaging of CD69 Visualizes T-Cell Activation and Predicts Survival Following Immunotherapy in Murine Glioblastoma

F. Lieberman, A. Panigrahy, I. Pollack, 2023, Cancer research communications.